Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 16 Nov 2022 for Biocryst Pharmaceuticals INC, €69k. Read the official filing
Filing timeline
BuySaleYarlagadda S. Babu
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Yarlagadda S. Babu: trading record in brief
Yarlagadda S. Babu discloses dealings in Biocryst Pharmaceuticals Inc to SEC (Form 4). Between 1 January 2016 and 14 November 2022, the trades on record add up to 6 filings.
Sales make up the whole of the open-market record (1 sale, €316k). The rest of the record consists of 3 share grants and 2 option exercises. 2022 to date brings no purchases and 1 sale.
The newest entry dates from 16 November 2022: an option exercise of €69k, in Biocryst Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Yarlagadda S. Babu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
50,000 shares@ US$1.427.6% of flowCommon StockSEC:0001127602-22-025761:0
20,000 shares@ US$17.1649.0% of flowCommon StockSEC:0001127602-22-008780:0
35,000 shares0Common StockSEC:0001127602-21-031134:0
62,000 shares@ US$4.7340.3% of flowCommon StockSEC:0001127602-21-030610:0
4,724 sharesCommon StockSEC:0001127602-16-037578:0
1,639 sharesCommon StockSEC:0001127602-16-035659:0
6 of 6 declarations
